Cure rates for teens and young adults with cancer have improved, but survivors face higher risks of being hospitalized than people in the general population because of the double-edged sword of cancer treatment, doctors say.
In the first study, doctors and researchers from the Danish Cancer Society Research Center in Copenhagen looked at the risk for hospitalization in 33,555 five-year young cancer survivors over six decades compared with people in the general population.
Survivors of leukemia, brain cancer and Hodgkin’s lymphoma — cancers characterized by particularly intensive and long treatments — were at highest risk, said Kathrine Rugbjerg, Dr. Jørgen Olsen and their co-authors.
“The findings underscore a great diversity of cancer-related health problems that physicians and patients should be knowledgeable about,” they said.
Dr. Paul Nathan, an oncologist at the Hospital for Sick Children in Toronto, treats and studies survivors of childhood cancer. He was not involved in the newly published research.
“What’s happened over time is that we have gotten better at using the tools at our disposal, chemotherapy, radiation, sometimes a bone marrow transplant, to cure patients. Compared to two or three decades ago, survival is very much improved. Eighty per cent of kids with cancer will survive. Thirty or 40 years ago, most of them didn’t,” Nathan said.
“The problem is, in order to achieve that, we have had to treat some patients more intensively and so we are seeing more survivors. Some of them, though, may have long-term consequences of the more intensive therapies.”
Potential long-term consequences include:
Nathan said that’s why if a 25-year-old cancer survivor walks into an emergency room with chest pain, it’s important to get their cancer history. Heart issues are otherwise rare for that age group and could be missed.
The second study by Kevin Krull of St. Jude Children’s Research Hospital in Memphis, Tenn., and his co-authors pointed to lower average scores in reading skills, attention, memory and processing speed among long-term survivors of childhood osteosarcoma — the type of bone cancer Canadian runner Terry Fox had.
The research describes different subsequent malignancies than those previously described, Dr. Karen Effinger and Dr. Michael Link of the Stanford University School of Medicine in California said in a journal editorial.
“While the progress made in the management of cancer in children and young adults has been gratifying, we must remember the words of Giulio D’Angio, who reminds us that ‘cure is not enough.'”
Neave Badanai, 16, of Thunder Bay, Ont., just received a clean bill from Nathan. She was diagnosed with a type of kidney cancer at age two and had two years of treatment.
“The cancer is kind of on the back burner,” Badanai said. “It is comforting knowing everything is under control.”
Nathan said the hope is that as therapies evolve, the long-term risks of causing new cancers, heart disease or learning difficulties will be reduced.